American Society of Addiction Medicine
American Society of Addiction Medicine
Transition to Extended-release Buprenorphine Injectable Within Seven Days for Opioid Use Disorder Treatment: A Scoping Narrative
Transition to Extended-release Buprenorphine Injectable Within Seven Days for Opioid Use Disorder Treatment: A Scoping Narrative
Transition to Extended-release Buprenorphine Injectable Within Seven Days for Opioid Use Disorder Treatment: A Scoping Narrative
Thursday 18th September 2025
Dr. Azar discusses transitioning to extended-release buprenorphine for opioid use disorder, sharing insights on rapid treatment protocols.
26 minutes
Informative
Inspiring
Educational
Eye-opening
Supportive
About this podcast
Author:
American Society of Addiction Medicine
Overview:
Categories:
Innovative Treatments & Recovery Paths
Navigating Alcohol Dependency
Family Recovery from Addiction
Navigating Intimate Relationships
Nutritional Pathways to Recovery
Links:
Visit site
Episodes:
46 (View all)
Do you want to link to this podcast?
Get the buttons here!Revolutionising Opioid Treatment: Dr. Azar's Approach
Episode Overview
- Transitioning patients rapidly to extended-release buprenorphine can reduce overdose risks.
- Understanding pharmacological nuances is crucial for effective treatment strategies.
- High opioid tolerance presents significant challenges in current treatment protocols.
- Creativity and innovation are vital in evolving addiction medicine practices.
- Future research needs to focus on generating high-level evidence for new protocols.
"Do what fascinates you, do what you love. It's amazing to go to work and not feel as though you're going to work."
Get ready to be moved by Dr. Pouya Azar's fascinating journey into addiction medicine. This episode of 'Addiction Medicine: Beyond the Abstract' takes listeners through the complexities of transitioning patients with opioid use disorder to extended-release buprenorphine injectable treatments. Dr. Azar, a clinician-scientist based in Vancouver, shares his insights on the benefits and challenges of rapid transitions, particularly for those using synthetic opioids like fentanyl.
His narrative review offers a fresh perspective on why current protocols may need to evolve to better serve patients facing high opioid tolerances and severe withdrawal symptoms. As Dr. Azar explains, understanding the pharmacological nuances is key to developing effective treatment strategies that can keep patients alive and reduce overdose risks. He also touches on the importance of creativity and innovation in medical research, encouraging budding addiction medicine professionals to think outside the box.
With a mix of personal anecdotes and scientific exploration, this episode provides a compelling look at how addiction medicine is adapting to new challenges. If you're curious about the future of opioid treatment and the role of extended-release medications, this episode is a must-listen. Could this innovative approach be the game-changer in addiction treatment we've been waiting for?